<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hamdan F</submitter><funding>European Research Council</funding><funding>Jane ja Aatos Erkon Säätiö</funding><funding>Jane ja Aatos Erkon Säätiö (Jane and Aatos Erkko Foundation)</funding><pagination>1757</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12914026</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(1)</volume><pubmed_abstract>Colorectal cancer (CRC) remains refractory to most immunotherapies, with cancer vaccines failing due to an immunosuppressive tumor microenvironment. Here, we show that β-glucan-induced trained immunity overcomes these barriers by reprogramming macrophages through H3K4me3-dependent epigenetic modifications and metabolic rewiring. In female mice vaccinated with peptide-coated adenovirus-based vaccine PeptiCrad, training enhances glycolysis with creatine metabolism sustaining CXCL9/10 production, enabling macrophages to recruit NK cells via CXCR3. In turn, NK cells produce CCL5, driving cDC1 infiltration and antigen presentation, which together amplify effector memory CD8⁺ T cell responses. Moreover, with human peripheral blood mononuclear cells and CRC patient-derived organoids, trained macr</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response.</pubmed_title><pmcid>PMC12914026</pmcid><funding_grant_id>4705796</funding_grant_id><funding_grant_id>681219</funding_grant_id><pubmed_authors>Hamdan F</pubmed_authors><pubmed_authors>D'Alessio F</pubmed_authors><pubmed_authors>Giannoula Y</pubmed_authors><pubmed_authors>Nieminen AI</pubmed_authors><pubmed_authors>Sakalauskaite M</pubmed_authors><pubmed_authors>Gandolfi S</pubmed_authors><pubmed_authors>Stigzelius V</pubmed_authors><pubmed_authors>Seppala TT</pubmed_authors><pubmed_authors>Russo S</pubmed_authors><pubmed_authors>Izci O</pubmed_authors><pubmed_authors>Cerullo V</pubmed_authors><pubmed_authors>Napolano A</pubmed_authors><pubmed_authors>Alanen KM</pubmed_authors><pubmed_authors>Zaghen E</pubmed_authors><pubmed_authors>Antignani G</pubmed_authors><pubmed_authors>Bottega P</pubmed_authors><pubmed_authors>Feodoroff M</pubmed_authors><pubmed_authors>Sandberg J</pubmed_authors><pubmed_authors>Zambrano N</pubmed_authors><pubmed_authors>Gronholm M</pubmed_authors><pubmed_authors>Chiaro J</pubmed_authors><pubmed_authors>Mustjoki S</pubmed_authors><pubmed_authors>Fusciello M</pubmed_authors><pubmed_authors>Eriksson O</pubmed_authors><pubmed_authors>Kolikova J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response.</name><description>Colorectal cancer (CRC) remains refractory to most immunotherapies, with cancer vaccines failing due to an immunosuppressive tumor microenvironment. Here, we show that β-glucan-induced trained immunity overcomes these barriers by reprogramming macrophages through H3K4me3-dependent epigenetic modifications and metabolic rewiring. In female mice vaccinated with peptide-coated adenovirus-based vaccine PeptiCrad, training enhances glycolysis with creatine metabolism sustaining CXCL9/10 production, enabling macrophages to recruit NK cells via CXCR3. In turn, NK cells produce CCL5, driving cDC1 infiltration and antigen presentation, which together amplify effector memory CD8⁺ T cell responses. Moreover, with human peripheral blood mononuclear cells and CRC patient-derived organoids, trained macr</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-16T06:32:47.155Z</modification><creation>2026-07-09T10:39:39.129Z</creation></dates><accession>S-EPMC12914026</accession><cross_references><pubmed>41605920</pubmed><doi>10.1038/s41467-026-68466-5</doi></cross_references></HashMap>